tradingkey.logo

Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)

ReutersDec 29, 2025 1:35 PM

- Unicycive Therapeutics Inc UNCY.O:

  • UNICYCIVE THERAPEUTICS ANNOUNCES RESUBMISSION OF NEW DRUG APPLICATION (NDA) FOR OXYLANTHANUM CARBONATE (OLC)

  • UNICYCIVE THERAPEUTICS INC - NDA RESUBMITTED AFTER VENDOR RESOLVES FDA DEFICIENCIES

  • UNICYCIVE THERAPEUTICS INC - NDA SUBMISSION REVIEW EXPECTED WITHIN 6 MONTHS PER PRESCRIPTION DRUG USER FEE ACT

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI